vs
GULFPORT ENERGY CORP（GPOR）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
GULFPORT ENERGY CORP的季度营收约是Orthofix Medical Inc.的1.8倍（$398.2M vs $219.9M），GULFPORT ENERGY CORP净利率更高（33.3% vs -1.0%，领先34.3%），GULFPORT ENERGY CORP同比增速更快（66.0% vs 2.0%），过去两年GULFPORT ENERGY CORP的营收复合增速更高（18.6% vs 8.0%）
Gulfport Energy Corp是一家总部位于美国的独立油气勘探生产企业，核心运营区域覆盖俄亥俄州尤蒂卡页岩区、俄克拉荷马州SCOOP产区，主要生产天然气、原油及天然气液，供应北美工业、公用事业及商业终端市场。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
GPOR vs OFIX — 直观对比
营收规模更大
GPOR
是对方的1.8倍
$219.9M
营收增速更快
GPOR
高出64.0%
2.0%
净利率更高
GPOR
高出34.3%
-1.0%
两年增速更快
GPOR
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $398.2M | $219.9M |
| 净利润 | $132.4M | $-2.2M |
| 毛利率 | 76.6% | 71.1% |
| 营业利润率 | 44.9% | 0.2% |
| 净利率 | 33.3% | -1.0% |
| 营收同比 | 66.0% | 2.0% |
| 净利润同比 | 148.5% | 92.4% |
| 每股收益（稀释后） | $7.98 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPOROFIX
| Q4 25 | $398.2M | $219.9M | ||
| Q3 25 | $379.7M | $205.6M | ||
| Q2 25 | $447.6M | $203.1M | ||
| Q1 25 | $197.0M | $193.6M | ||
| Q4 24 | $239.9M | $215.7M | ||
| Q3 24 | $253.9M | $196.6M | ||
| Q2 24 | $181.1M | $198.6M | ||
| Q1 24 | $283.2M | $188.6M |
净利润GPOROFIX
| Q4 25 | $132.4M | $-2.2M | ||
| Q3 25 | $111.4M | $-22.8M | ||
| Q2 25 | $184.5M | $-14.1M | ||
| Q1 25 | $-464.0K | $-53.1M | ||
| Q4 24 | $-273.2M | $-29.1M | ||
| Q3 24 | $-14.0M | $-27.4M | ||
| Q2 24 | $-26.2M | $-33.4M | ||
| Q1 24 | $52.0M | $-36.0M |
毛利率GPOROFIX
| Q4 25 | 76.6% | 71.1% | ||
| Q3 25 | 74.6% | 72.2% | ||
| Q2 25 | 80.7% | 68.7% | ||
| Q1 25 | 57.9% | 62.8% | ||
| Q4 24 | 63.2% | 69.0% | ||
| Q3 24 | 64.6% | 68.7% | ||
| Q2 24 | 52.2% | 67.8% | ||
| Q1 24 | 69.4% | 67.5% |
营业利润率GPOROFIX
| Q4 25 | 44.9% | 0.2% | ||
| Q3 25 | 41.9% | -8.3% | ||
| Q2 25 | 56.0% | -7.9% | ||
| Q1 25 | 6.1% | -25.2% | ||
| Q4 24 | -131.3% | -5.3% | ||
| Q3 24 | 5.7% | -9.6% | ||
| Q2 24 | -10.0% | -12.5% | ||
| Q1 24 | 28.9% | -15.6% |
净利率GPOROFIX
| Q4 25 | 33.3% | -1.0% | ||
| Q3 25 | 29.3% | -11.1% | ||
| Q2 25 | 41.2% | -6.9% | ||
| Q1 25 | -0.2% | -27.4% | ||
| Q4 24 | -113.9% | -13.5% | ||
| Q3 24 | -5.5% | -13.9% | ||
| Q2 24 | -14.5% | -16.8% | ||
| Q1 24 | 18.4% | -19.1% |
每股收益（稀释后）GPOROFIX
| Q4 25 | $7.98 | $-0.05 | ||
| Q3 25 | $4.45 | $-0.57 | ||
| Q2 25 | $9.12 | $-0.36 | ||
| Q1 25 | $-0.07 | $-1.35 | ||
| Q4 24 | $-14.72 | $-0.76 | ||
| Q3 24 | $-0.83 | $-0.71 | ||
| Q2 24 | $-1.51 | $-0.88 | ||
| Q1 24 | $2.34 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8M | $82.0M |
| 总债务越低越好 | $788.2M | — |
| 股东权益账面价值 | $1.8B | $450.0M |
| 总资产 | $3.0B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资GPOROFIX
| Q4 25 | $1.8M | $82.0M | ||
| Q3 25 | $3.4M | $62.9M | ||
| Q2 25 | $3.8M | $65.6M | ||
| Q1 25 | $5.3M | $58.0M | ||
| Q4 24 | $1.5M | $83.2M | ||
| Q3 24 | $3.2M | $30.1M | ||
| Q2 24 | $1.2M | $26.4M | ||
| Q1 24 | $8.2M | $27.0M |
总债务GPOROFIX
| Q4 25 | $788.2M | — | ||
| Q3 25 | $691.7M | $157.2M | ||
| Q2 25 | $695.2M | $157.0M | ||
| Q1 25 | $700.4M | $156.9M | ||
| Q4 24 | $702.9M | $157.0M | ||
| Q3 24 | $694.4M | $118.5M | ||
| Q2 24 | $679.5M | $118.0M | ||
| Q1 24 | $636.4M | $118.2M |
股东权益GPOROFIX
| Q4 25 | $1.8B | $450.0M | ||
| Q3 25 | $1.8B | $442.5M | ||
| Q2 25 | $1.8B | $458.3M | ||
| Q1 25 | $1.7B | $458.3M | ||
| Q4 24 | $1.7B | $503.1M | ||
| Q3 24 | $2.1B | $525.9M | ||
| Q2 24 | $2.1B | $546.0M | ||
| Q1 24 | $2.2B | $570.3M |
总资产GPOROFIX
| Q4 25 | $3.0B | $850.6M | ||
| Q3 25 | $2.9B | $832.6M | ||
| Q2 25 | $3.0B | $837.2M | ||
| Q1 25 | $2.9B | $823.1M | ||
| Q4 24 | $2.9B | $893.3M | ||
| Q3 24 | $3.2B | $867.9M | ||
| Q2 24 | $3.2B | $882.0M | ||
| Q1 24 | $3.3B | $906.0M |
负债/权益比GPOROFIX
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.38× | 0.36× | ||
| Q2 25 | 0.39× | 0.34× | ||
| Q1 25 | 0.42× | 0.34× | ||
| Q4 24 | 0.41× | 0.31× | ||
| Q3 24 | 0.34× | 0.23× | ||
| Q2 24 | 0.32× | 0.22× | ||
| Q1 24 | 0.29× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $185.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流GPOROFIX
| Q4 25 | $185.4M | $27.7M | ||
| Q3 25 | $209.1M | $12.4M | ||
| Q2 25 | $231.4M | $11.6M | ||
| Q1 25 | $177.3M | $-18.4M | ||
| Q4 24 | $148.8M | $23.7M | ||
| Q3 24 | $189.7M | $11.7M | ||
| Q2 24 | $123.5M | $9.0M | ||
| Q1 24 | $188.0M | $-18.6M |
自由现金流GPOROFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率GPOROFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度GPOROFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率GPOROFIX
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPOR
| Natural Gas Production | $296.9M | 75% |
| Other | $42.7M | 11% |
| Naturalgasliquidsales | $35.2M | 9% |
| Oil And Condensate | $23.4M | 6% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
